Axogen (AXGN) Net Cash Flow Growth (1y) (2011 - 2026)
Axogen (AXGN) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -54.17% |
| 10 | Axogen | 2.44 Bn | 2.33 Bn | 50.67 Mn | 514.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 514.33% |
| Mar 31, 2026 | 576.91% |
| Dec 31, 2025 | 30.97% |
| Sep 30, 2025 | 454.08% |
| Jun 30, 2025 | -44.19% |
| Mar 31, 2025 | 38.24% |
| Dec 31, 2024 | 12,802.86% |
| Sep 30, 2024 | -106.91% |
| Jun 30, 2024 | -77.59% |
| Mar 31, 2024 | -102.13% |
| Dec 31, 2023 | -107.25% |
| Sep 30, 2023 | 205.37% |
| Jun 30, 2023 | 666.54% |
| Mar 31, 2023 | 58.37% |
| Dec 31, 2022 | 106.87% |
| Sep 30, 2022 | 139.34% |
| Jun 30, 2022 | -120.69% |
| Mar 31, 2022 | -92.91% |
| Dec 31, 2021 | -17.13% |
| Sep 30, 2021 | 65.35% |